The AHRQ PSNet Collection comprises an extensive selection of resources relevant to the patient safety community. These resources come in a variety of formats, including literature, research, tools, and Web sites. Resources are identified using the National Library of Medicine’s Medline database, various news and content aggregators, and the expertise of the AHRQ PSNet editorial and technical teams.
Ensing HT, Vervloet M, van Dooren AA, et al. Int J Clin Pharm. 2018;40:712-720.
This qualitative study found that postdischarge home visits from pharmacists focused on the details of the medication regimen rather than health beliefs and extent of medication adherence. The authors recommend an increased focus on patient engagement during these home visits.
Ensing HT, Koster ES, Stuijt CCM, et al. Int J Clin Pharm. 2015;37:430-4.
Patients are susceptible to various problems following hospital discharge, including medication errors. This commentary suggests that improving the transfer of patient medication history, performing home visits to follow up with patients, and collaboration between primary care and community pharmacy can help reduce adverse drug events after patients are discharged from the hospital.
Cheung K-C, van der Veen W, Bouvy ML, et al. J Am Med Inform Assoc. 2014;21:e63-70.
… the hospital setting. This study, which analyzed data from a national database of medication errors in the Netherlands, … poorly designed screens and displays, were at the root of a large proportion of these errors. Dr. Donald Norman, a … factors engineering field, was interviewed by AHRQ WebM&M in 2009. …
Cheung K-C, Wensing M, Bouvy ML, et al. BMJ Qual Saf. 2012;21:1009-18.
… about emerging safety issues. The Joint Commission's Sentinel Event Alerts and the Institute for Safe Medication … only one of those recommendations had been implemented by a majority of pharmacies. The authors conclude that passive …
Klopotowska JE, Wierenga PC, Smorenburg SM, et al. Eur J Clin Pharmacol. 2013;69:75-85.
Medical teams were generally able to recognize serious adverse drug events (ADEs) in hospitalized patients, but were less consistent in identifying ADEs with more subtle symptoms or those resulting only in abnormal laboratory test results.